| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000230530.1 |
Docetaxel |
Bladder urothelial carcinoma |
0.048685905 |
Resistant |
| ENSG00000230530.1 |
Docetaxel |
Breast invasive carcinoma |
0.03275844 |
Resistant |
| ENSG00000230530.1 |
Docetaxel |
Brain lower grade glioma |
0.022869891 |
Resistant |
